Day: September 5, 2024

Bishop Street Underwriters Acquires Conifer Insurance Services

Written by Customer Service on September 5, 2024. Posted in Mergers And Acquisitions.

Acquisition is Bishop Street’s First Entry into the Commercial P&C MGA Market NEW YORK and TROY, Mich., Sept. 05, 2024 (GLOBE NEWSWIRE) — Bishop Street Underwriters (“Bishop Street”), a multi-boutique insurance platform owned by RedBird Capital Partners (“RedBird”), today announced it has acquired Conifer Insurance Services (“Conifer” or “CIS”), a specialty commercial managing general agency (“MGA”) from Conifer Holdings, Inc. (Nasdaq: CNFR). The acquisition of Conifer marks Bishop Street’s entry into commercial lines, expanding its multiline, differentiated MGA platform. Conifer operates a portfolio of three programs across several specialty lines of business, including main street small and medium sized enterprises (SMEs), hospitality and auto dealers. Conifer’s existing infrastructure presents a significant growth opportunity...

SAIC Announces Second Quarter of Fiscal Year 2025 Results

Written by Customer Service on September 5, 2024. Posted in Earnings Releases And Operating Results.

Revenues of $1.82 billion; 2% organic growth Net income of $81 million; Adjusted EBITDA(1) of $170 million or 9.4% of revenues Diluted earnings per share of $1.58; Adjusted diluted earnings per share(1) of $2.05 Cash flows provided by operating activities of $138 million; free cash flow(1) of $241 million Net bookings of $1.2 billion; book-to-bill ratio of 0.6; trailing twelve months book-to-bill ratio of 1.1 Company increases Adjusted Diluted EPS(1) Fiscal Year 2025 guidance to $8.10 – $8.30 and reaffirms all other Fiscal Year 2025 financial guidanceRESTON, Va., Sept. 05, 2024 (GLOBE NEWSWIRE) — Science Applications International Corporation (Nasdaq: SAIC), a premier Fortune 500® technology integrator driving our nation’s digital transformation across the defense, space, civilian, and intelligence markets, today...

Affimed Reports Second Quarter 2024 Financial Results & Business Update

Written by Customer Service on September 5, 2024. Posted in Earnings Releases And Operating Results.

AFM24 combination with atezolizumab: 24 patients treated in the EGFR mutant (EGFRmut) non-small cell lung cancer (NSCLC) cohort; in 17 response-evaluable patients: 1 complete response (CR), 3 partial responses (PRs) and 8 stable diseases (SDs) were reported. Objective response rate (ORR) is 23.5% (4/17) and disease control rate (DCR) is 70.6% (12/17). Median follow-up of > 7 months, 8 of 17 patients continue on treatment. The EGFR wild type (EGFRwt) cohort of treatment refractory NSCLC patients has treated 40 patients; ORR and safety data is expected in Q4 2024 Acimtamig (AFM13) combination with AlloNK® (AB-101): Enrollment for relapsed/refractory (r/r) Hodgkin Lymphoma (HL) patients in cohorts 1 and 2 is completed (n=12); cohort 3 and cohort 4 recruitment on track (10/12 patients). In cohort 1 and 2, an ORR of 83.3% (10/12) and a complete...

UTStarcom Reports Unaudited Financial Results for First Half of 2024

Written by Customer Service on September 5, 2024. Posted in Earnings Releases And Operating Results.

HANGZHOU, China, Sept. 05, 2024 (GLOBE NEWSWIRE) — UTStarcom (“UT,” “UTStarcom” or the “Company”) (NASDAQ: UTSI), a global telecommunications infrastructure provider, today reported its unaudited financial results and a business update for the six months ended June 30, 2024 (“the first half”). Business Highlights:Expansion order for the mobile transport network of a Mobile Operator in Europe. In 1H 2024, UTStarcom received a new order for an updated NetRing PTN product that includes certain new features required by the customer to address its network expansion plans. UT also works with the customer on SDN solution integration and testing to enable the customer’s network evolution. Expansion order for the Broadband Core solution in India. Further expansion order for IMS solution deployed with one of our key Indian customers, including...

Tecnoglass Announces Third Quarter 2024 Dividend

Written by Customer Service on September 5, 2024. Posted in Public Companies.

Miami, FL, Sept. 05, 2024 (GLOBE NEWSWIRE) — Tecnoglass, Inc. (NYSE: TGLS) (“Tecnoglass” or the “Company”), a leading producer of high-end aluminum and vinyl windows and architectural glass for the global residential and commercial end markets, today announced that its Board of Directors has declared a quarterly dividend of $0.11 per share, or $0.44 per share on an annualized basis, for the third quarter of 2024. Shareholders of record as of the close of business on September 30, 2024 will be paid a dividend on October 31, 2024. About Tecnoglass Tecnoglass Inc. is a leading producer of high-end aluminum and vinyl windows and architectural glass serving the multi-family, single-family, and commercial end markets. Tecnoglass is the second largest glass fabricator serving the U.S. and the #1 architectural glass...

Katapult to Participate in H.C. Wainwright 26th Annual Global Investment Conference

Written by Customer Service on September 5, 2024. Posted in Public Companies.

PLANO, Texas, Sept. 05, 2024 (GLOBE NEWSWIRE) — Katapult Holdings, Inc. (“Katapult” or the “Company”) (NASDAQ: KPLT), an e-commerce focused financial technology company, announced that Orlando Zayas, CEO, and Nancy Walsh, CFO, will participate in the H.C. Wainwright 26th Annual Global Investment Conference, which is being held September 9 to 11, 2024. Orlando Zayas will deliver a presentation that will discuss an overview of the Katapult business. The presentation will be available virtually, on-demand beginning at 7:00 AM ET on September 9, 2024. The on-demand audio webcast of the event will be available on the Company’s Investor Relations website (https://ir.katapultholdings.com/). If you are an institutional investor, and would like to listen to the Company’s presentation through the conference website, please click on the following...

Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences

Written by Customer Service on September 5, 2024. Posted in Public Companies.

BOSTON and SAN DIEGO, Sept. 05, 2024 (GLOBE NEWSWIRE) — Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company focused on discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders, today announced presentations at two upcoming medical conferences: the International League Against Epilepsy (ILAE) 15th Annual European Epilepsy Congress (EEC) in Rome, Italy, September 7-11, 2024, and the 2024 Epilepsy Foundation Pipeline Conference in Atlanta, Ga., September 25-26, 2024. At EEC, Rapport will present on the novel design of a Phase 2a proof-of-concept trial for the company’s lead product candidate RAP-219, which is being studied in patients with drug-resistant focal epilepsy. At the Epilepsy Foundation Pipeline Conference, Rapport...

Agios to Present at the 2024 Cantor Global Healthcare Conference on September 18, 2024

Written by Customer Service on September 5, 2024. Posted in Public Companies.

CAMBRIDGE, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that the company is scheduled to present at the 2024 Cantor Global Healthcare Conference on Wednesday, September 18, 2024, at 10:20 a.m. ET. A live webcast of the presentation can be accessed under “Events & Presentations” in the Investors section of the company’s website at www.agios.com. A replay of the webcast will be archived on the company’s website for at least two weeks following the presentation. About AgiosAgios is the pioneering leader in PK activation and is dedicated to developing and delivering transformative therapies for patients living with rare diseases. In the U.S., Agios markets a first-in-class...

Auddia Announces Industry First AI Podcast Player Added to faidr

Written by Customer Service on September 5, 2024. Posted in Public Companies.

Forward+ and Chapter Visualization Leverage Auddia’s Advanced AI Technology to Introduce Leading Podcast Listening Experience Technology Now Available on iOS With Android Targeted for Q4 Features are First Clearly Differentiated Offerings for Podcast Listening on faidr BOULDER, CO, Sept. 05, 2024 (GLOBE NEWSWIRE) — Auddia Inc. (NASDAQ:AUUD) (NASDAQ:AUUDW) (“Auddia” or the “Company”), a proprietary AI platform for audio identification and classification and related technologies, reinventing how consumers engage with AM/FM radio, podcasts, and other audio content, today announced it recently launched two new differentiated features for podcast listening on the iOS faidr mobile application, Forward+ and Chapter Visualization. Both features are built on the Company’s proprietary audio classification AI and Natural Language Processing...

Aclarion Launches Surgeon Partnership to Apply Nociscan’s AI Technology to Personal Injury and Workers Compensation Market

Written by Customer Service on September 5, 2024. Posted in Public Companies.

Justin Kubeck, M.D. of Ocean Pain and Spine in Toms River, NJ Will Lead a Statewide Network of Providers That Use Nociscan to Better Serve This Important Segment of Low Back Pain Population Average Settlement in New Jersey for Personal Injury Claims Involving the Neck and Back is $918,967 Work-related Accidents Which Cause Neck and Back Injuries Have a National Average Settlement of $148,750 BROOMFIELD, CO, Sept. 05, 2024 (GLOBE NEWSWIRE) — Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today the launch of a program to develop a statewide network of providers in New Jersey to utilize Nociscan throughout the personal...

Day: September 5, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals